More than 3 billion people worldwide lived with a neurological condition in 2021, new study reports

Researchers estimated global, regional, and national health loss due to 37 nervous system conditions and their associated risk factors from 1990 to 2021.

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit – Psychedelic Alpha

NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

October 31, 2023

New program launched to accelerate access to personalized therapies for children with rare conditions

Today, Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop a pathway for children

December 4, 2023

2024 Nobel Prize winner Gary Ruvkun on sharing credit and the future of microRNA

Gary Ruvkun is used to getting awards — but for him, the Nobel Prize is in a class of its own. “I’ve won 10 to

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.